Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for TAZVERIK® (tazemetostat) has been granted conditional approval in China for the treatment of ...

An extraordinary rescue operation nears its end, as two children from Gaza arrive in the US for cancer treatment.

Cancer is one of the leading causes of death in dogs, with diagnosis ranging from lymphoma to mast cell tumors. A recent ...

A Trump executive order forming the commission tasked them with assessing the ‘threat posed by’ ADHD meds. Learn how experts ...

We spoke to five people about their weight loss and the very different health problems that caused it, while experts explain what to look ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) ...

Democrats do not want to repeat the mistakes of last week, when they split over the GOP's stopgap measure to avoid a federal ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and EMA marketing authorizations ...

A White House ... Dr. Wiznitzer. Also, Congress has procedures that must be followed to change the way a drug is administered. If the MAHA commission determines that ADHD drugs (or any drugs on ...

Dr. Amy Herold, an OB-GYN and chief administrative and chief medical officer for Providence Queen of the Valley Medical Center in Napa, said her region is known for its tourism but is really a ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and ...